Send this to a friend

Day and Zindrick enter Aeromics' board of directors

Mark Day and Thomas Zindrick joined the board of directors at Aeromics, a Branford-based clinical-stage pharmaceutical company focused on controlling brain swelling in stroke survivors.

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media